Skip to content
★ Sign in to follow
Clearbridge Health Limited logo

Clearbridge Health Limited Stock: price and insider trades · Singapore

ISIN SG1EB6000000SG·Mcap SGD 6.4MHealth Care

No insider purchase over the last 90 days. The latest, by CHEN JOHNSON, was filed 06 May 2025.

Clearbridge Health Limited: what insiders have been doing

Every trade that managers of Clearbridge Health Limited disclose to SGX is tracked on this page. The company sits in the Health Care sector. 1 insider has disclosed 7 filings since 27 October 2025.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

There has been no open-market purchase by an insider of Clearbridge Health Limited for at least a year.

With 7 filings in twelve months, the company is more active than the median of 6 filings across the 394 companies we follow on the same exchange. The full history, which starts in 2017, counts 47 purchases against 3 sales.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. Source: insider filings from SGX. Past trades are no guide to future returns.

Insider Decl.
77
Thresholds
n/a
Buy Volume
€5M
47 ops. · all time
Sell Volume
€107,155
3 ops. · all time

Who traded when

BuySale
Chen Johnson2 buys
Yee Pinh Jeremy2 buys
Coop International Pte. Ltd.1 buy
Ong Choon Yi1 buy
Wong Kong Leong1 sale

Since the insiders bought

  • Filed 06 May 2025 · 551 days ago · €169k
    -66.7%
    Entry SGD 0.00 · Close at T+365 SGD 0.00
  • Filed 06 May 2025 · 551 days ago · €338k
    -66.7%
    Entry SGD 0.00 · Close at T+365 SGD 0.00
  • Filed 06 May 2025 · 551 days ago · €1.0M
    -66.7%
    Entry SGD 0.00 · Close at T+365 SGD 0.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2025

FY ended December 2025 · cache

SGD 0.00
Analyst consensus
·
Income statement
RevenueSGD 9.9M
Gross profitSGD 5.1M51% margin
EBITDA-SGD 11.6M-117% margin
Net income-SGD 12.9M-119.2% margin
Valuation
P/Book1.0x
Beta0.12
Balance sheet & cash
Market capSGD 6.4M
Total debtSGD 1.5M
Free Cash Flow-SGD 2.8M
Debt / Equity10%
Profitability & ownership
ROE-116.4%
ROA-10.8%
% insiders61.5%
% institutions2.5%
Last declaration on 2 July 2026
Declarations77 total
  • ●
    Related company / holdingExecutives(filed)
    0SGX
    ShareSGX-STSGX:ANNK2YZUE6XHU2L2
  • ●
    Related company / holdingExecutives(filed)
    0SGX
    ShareSGX-STSGX:GTZC7B7WVCFAIUYL
  • ●
    Related company / holdingExecutives(filed)
    0SGX
    ShareSGX-STSGX:6CQU6WZKESIPEH31
  • ●
    Related company / holdingExecutives(filed)
    0SGX
    ShareSGX-STSGX:7SDNUZ8MAWQRT4CB
  • ●
    Related company / holdingExecutives(filed)
    0SGX
    ShareSGX-STSGX:QVIO4DTBGBRUL3OD
  • ●
    Related company / holdingExecutives(filed)
    0SGX
    ShareSGX-STSGX:2YPNTISFPTUC841D
  • ●
    Related company / holdingExecutives(filed)
    0SGX
    ShareSGX-STSGX:JJQBHA08LU00QH72
  • ●
    Substantial ShareholderExecutives(filed)
    0SGX
    ShareSGX-STISIN SG1EB6000000SGX:RJSR0A75MH5J2JS4
  • ●
    Related company / holdingExecutives
    0SGX
    ShareSGX-STISIN SG1EB6000000SGX:4OCCBKVTU8HZDVLT
  • ●
    Substantial ShareholderExecutives(filed)
    0SGX
    ShareSGX-STISIN SG1EB6000000SGX:0BTZHO5I6KPK8RY0
  • ▼
    Substantial ShareholderExecutives(filed)
    160,000 SGD13SGX
    80,000,000 shares@ SGD 0.002100.0% of flowShareSGX-STISIN SG1EB6000000SGX:OZ8AGHJYT7TQ0P8E
  • ▲
    Director/CEOExecutives
    250,000 SGD43SGX
    80,645,161 shares@ SGD 0.003160.8% of flowShareSGX-STISIN SG1EB6000000SGX:M33XGQW1AUBHKWUQ
    Canonical exit: 31 Jul 2025 (T+90)
  • ▲
    Director/CEOExecutives
    500,000 SGD42SGX
    161,290,322 shares@ SGD 0.003181.2% of flowShareSGX-STISIN SG1EB6000000SGX:D0VUP3EBXBDZ86RG
    Canonical exit: 31 Jul 2025 (T+90)
  • ●
    Substantial ShareholderExecutives(filed)
    0SGX
    ShareSGX-STISIN SG1EB6000000SGX:CO1UM5XNM3Z8X1D1
  • ▲
    Related company / holdingExecutives
    2M SGD13SGX
    483,870,967 shares@ SGD 0.0031100.0% of flowShareSGX-STISIN SG1EB6000000SGX:QV93HSAQPB7P4IO4
    Canonical exit: 31 Jul 2025 (T+90)
  • ●
    Related company / holdingExecutives
    0SGX
    ShareSGX-STISIN SG1EB6000000SGX:VAJFWD5KMMJU2JJG
  • ▲
    Substantial ShareholderExecutives(filed)
    959,450 SGD13SGX
    309,500,000 shares@ SGD 0.0031100.0% of flowShareSGX-STISIN SG1EB6000000SGX:HKO6RQZZKVH6D40J
    Canonical exit: 14 Apr 2025 (T+90)
  • ●
    Substantial ShareholderExecutives(filed)
    0SGX
    ShareSGX-STISIN SG1EB6000000SGX:P8CKGIBULDS8OVWD
  • ●
    Substantial ShareholderExecutives(filed)
    0SGX
    ShareSGX-STISIN SG1EB6000000SGX:53PPO74LJPPBFIMB
  • ▲
    Director/CEOExecutives
    154,110 SGD38SGX
    77,055,100 shares@ SGD 0.00239.2% of flowShareSGX-STISIN SG1EB6000000SGX:9DU86AHVE3004UJ2
    Canonical exit: 10 Mar 2025 (T+90)
  • ▲
    Director/CEOExecutives
    110,741 SGD24SGX
    55,370,554 shares@ SGD 0.00218.8% of flowShareSGX-STISIN SG1EB6000000SGX:37PZQ50BGD7O9AEB
    Canonical exit: 10 Mar 2025 (T+90)
  • ●
    Director/CEOExecutives
    0SGX
    4,195,200 sharesShareSGX-STISIN SG1EB6000000SGX:41T1C1NCBVDZ5QQ5
  • ●
    Director/CEOExecutives
    0SGX
    55,370,554 sharesShareSGX-STISIN SG1EB6000000SGX:R0EGTIP6UE3CU6VJ
  • ●
    Director/CEOExecutives
    0SGX
    154,110,200 sharesShareSGX-STISIN SG1EB6000000SGX:231T3PQWDXNRU43L
  • ▲
    Director/CEOExecutives
    15,750 SGD0SGX
    50,000 shares@ SGD 0.315ShareSGX-STISIN SG1EB6000000SGX:7XP4QZ451L60F6L6
    Canonical exit: 26 Mar 2018 (T+90)

25 of 77 declarations

About Clearbridge Health Limited

Clearbridge Health Limited is a company listed on the XSES market, specializing in the healthcare sector.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations